Miromatrix Presenting at the 2023 American Transplant Congress
May 30, 2023 16:08 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., May 30, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Announces Participation in the 20th Annual Craig-Hallum Institutional Investor Conference
May 30, 2023 16:05 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., May 30, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update
May 11, 2023 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix to Report First Quarter 2023 Financial Results
April 27, 2023 18:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., April 27, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Med
April 10, 2023 07:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., April 10, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
April 05, 2023 06:50 ET
|
Miromatrix Medical Inc.
CareDx Exclusive Provider of dd-cfDNA Testing Services for Use in Miromatrix Clinical Trials Companies at Forefront of Alternative Organ Supply Research to Address Organ Shortage BRISBANE,...
Miromatrix Reports Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
March 31, 2023 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., March 31, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix to Report Fourth Quarter and Full Year 2022 Financial Results
March 15, 2023 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., March 15, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix Medical Inc. Announces Pricing of $10 Million Public Offering of Common Stock
March 07, 2023 20:35 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., March 07, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (“Miromatrix”) (Nasdaq: MIRO), a life sciences company pioneering a novel technology for bioengineering fully...
Miromatrix Medical Inc. Announces Proposed Public Offering of Common Stock
March 07, 2023 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., March 07, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (“Miromatrix”) (Nasdaq: MIRO), a life sciences company pioneering a novel technology for bioengineering fully...